Livea Review
Best for: Comprehensive physician-supervised GLP-1; compounded sema $99/mo; 8 clinics + telehealth, MN/WI/IA/FL only
Livea is a physician-supervised medical weight loss clinic founded in 2011 with 8 clinics in MN and WI, plus telehealth in MN, WI, Iowa, and Florida. LegitScript certified, Livea prescribes compounded semaglutide (from $99/mo) and compounded tirzepatide (from $199/mo when available), with the program bundling InBody scans, registered dietitian nutrition, health coaching, and regular provider check-ins. With 50,000+ clients served and five consecutive Minnesota's Best Weight Loss Program wins, medical services are delivered by Livea Medical, PLLC, a physician-owned practice.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Billed separately
Coaching
Included
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Livea is one of the most affordable GLP-1 options on the market.
Livea at a glance
- Type
- GLP-1 telehealth provider
- Starting price
- $99/mo (Verbatim from /glp-1/ FAQ: 'compounded semaglutide starting at $99/month.' Once-weekly injectable. Medical page discloses separate $69/mo program fee covering consultation and supervision — whether $99/mo is inclusive of or additive to the program fee is clarified at free consultation.)
- What's included
- Medication · Consult · Shipping · Coaching
- Availability
- 4 states
- FDA status
- No FDA warning letter on record
How we scored Livea
Each dimension is scored algorithmically from Livea’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.6/10At $99/mo, Livea runs about 42% below the $170 median for GLP-1 providers.
Effectiveness25%
7.6/10Livea offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.9/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
6.8/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-07-05).
Accessibility10%
5.1/10Livea operates in a limited 4-state footprint — check availability first.
Support10%
7.3/10Coaching/dietitian access included.
How we verified this Livea review
Last checked 2026-07-05- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in 4 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications Livea offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Verbatim from /glp-1/ FAQ: 'compounded semaglutide starting at $99/month.' Once-weekly injectable. Medical page discloses separate $69/mo program fee covering consultation and supervision — whether $99/mo is inclusive of or additive to the program fee is clarified at free consultation.
Verbatim from /glp-1/ FAQ: 'Compounded tirzepatide starts at $199/month when available.' Availability subject to FDA compounding status — as of mid-2026 Livea states the FDA shortage end affects compounded tirz; Livea monitors and offers eligibility-based options including branded alternatives.
Ready to get started?
Plans and promotions change often — check Livea's current pricing and active discounts before you decide.
What we like
- LegitScript certified; physician-owned Livea Medical PLLC; Medical Director Dr. Paul Olson, internal medicine/nephrology, 40 years experience
- Compounded sema from $99/mo and tirz from $199/mo — significantly cheaper than brand Ozempic/Wegovy ($1,000+/mo self-pay)
- Comprehensive program: InBody scans, registered dietitian nutrition counseling, health coaching, and regular provider check-ins included
- 15+ years established (founded 2011); 50,000+ clients served; voted Minnesota's Best Weight Loss Program 5 consecutive years
- Medications shipped to door; same-day consultations; in-person or telehealth; typically HSA/FSA eligible
Watch-outs
- Telehealth limited to 4 states only (MN, WI, IA, FL) — unavailable to most of the US; primarily a regional clinic network
- Pricing ambiguous: $69/mo program fee plus separate medication cost ($99/mo sema) may bring GLP-1 total to ~$168/mo
- Compounded tirzepatide availability uncertain — FDA announced shortage end in 2026; access subject to eligibility
- Labs (bloodwork) not explicitly included in any published program tier; confirmed at consultation only
- Strong MN/WI clinic focus; telehealth reach into IA and FL is newer and less established than core markets
Is Livea worth it? Our verdict
Livea positions itself around one thing: Comprehensive physician-supervised GLP-1; compounded sema $99/mo; 8 clinics + telehealth, MN/WI/IA/FL only. It runs $99/month — toward the affordable end of the market. Coaching and follow-up are part of the package, not an upsell.
Beyond the core GLP-1 program, Livea leans on Compounded Sema & Tirz, Physician-Supervised, and Telehealth MN/WI/IA/FL.
How much Livea actually costs
- Compounded semaglutide — $99/month
- Compounded tirzepatide — $199/month
That puts Livea below the roughly $170 median ongoing price across the GLP-1 providers we track — a real cost advantage.
For a direct comparison, Telos Rx runs semaglutide and tirzepatide from $49/month — worth pricing against Livea before you commit.
Medications: what Livea prescribes
Livea prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the pair backed by the largest published weight-loss trials. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who Livea is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost.
- want coaching and follow-up included, not sold separately.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
Livea is available in 4 states. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Livea earns its place on the shortlist mainly on price: at $99/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
Ready to start with Livea?
Starting at $99/month. See current pricing and start your free consultation.
Alternatives to Livea
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Livea review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Livea?
Starting at $99/month. See current pricing and start your free consultation.